Bone marrow concentrate during hip surgery for labral tears and hip impingement
Tests bone marrow aspirate concentrate added to hip arthroscopy for labral tears in adults.
Key facts
- Who runs it
- Massachusetts General Hospital
- Where
- Boston, United StatesSee the site
- Trial code
- Registry title
- Effect of PRP, PPP, & BMAC on Functional Outcomes Following Hip Arthroscopy for Acetabular Labral Pathologies
- Status
- Recruiting
- Phase
- Phase 3
- People taking part
- 160 people, planned
- Started
- 30 Aug 2023
- Expected to end
- 30 Aug 2045
- Type of study
- Interventional, 2 groupsOne group gets a placebo (a dummy treatment), for comparison.
- Treatments tested
- Bone marrow aspirate concentrate (BMAC)
- Control
- Record updated
- 20 November 2024
Who can take part
AI summary
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for adults who need hip arthroscopy (keyhole hip surgery) to treat a problem of the labrum, the rim of cartilage around the hip socket. Some will also get PRP/PPP/BMAC, made from their own blood or bone marrow.
- Age
- 18 years or older
- Sex
- All sexes
- Disease stage
- A labral problem of the hip where the study doctor has decided hip arthroscopy is needed.
- Earlier treatment
- No earlier surgery on the same hip, such as hip arthroscopy, core decompression or periacetabular osteotomy.
Main reasons for not taking part
- People who do not speak English cannot join, because the surveys are only checked in English.
- Earlier surgery on the same hip
- Not willing to be placed by chance in either study group
The registry criteria, word for word
Show all 5 criteriaShow less
Who can take part
- Age: > or equal to 18 years
- Clinically indicated for hip arthroscopy (by the study PI) to address a labral pathology
- Willingness to participate, amenable to randomization into either treatment arm of the research study, and the ability to understand \& sign the informed consent document
Who cannot take part
- Prior same site (i.e., ipsilateral hip) surgery, including but not limited to previous hip arthroscopy, core decompression, or periacetabular osteotomies
- Non-English speaking (PROM surveys are only validated in English)
Where in United States
- Massachusetts General HospitalBoston, United StatesContact: Scott D. Martin, MDTaking people
About the trial
What the trial wants to find out
The goal of this clinical trial is to assess the effect of PRP/PPP/BMAC application on functional outcomes after hip arthroscopy to address acetabular labral pathologies. The main questions it aims to answer are:
Read full original descriptionShow less
1. Does PRP/PPP/BMAC application improve functional outcomes after hip arthroscopy to address acetabular labral pathologies? 2. Does PRP/PPP/BMAC application reduce the arthritic burden as measured by functional outcomes following hip arthroscopy to address labral pathologies with concomitant PRP/PPP/BMAC application?
The 2 groups in the trial
- Bone marrow aspirate concentrate (BMAC)Treatment being tested
Patients randomly allocated to receive BMAC will undergo hip arthroscopy and will receive PRP/PPP/BMAC application through the PI's standardized method of harvest, processing, and application.
- ControlPlacebo, for comparison
Patients allocated to the control cohort will receive standard of care hip arthroscopy without PRP/PPP/BMAC application.
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.
- Official title
- Effect of Platelet-Rich Plasma, Platelet-Poor Plasma, & Bone Marrow Aspirate Concentrate Application on Functional Outcomes Following Hip Arthroscopy for Acetabular Labral Pathologies: A Prospective Randomized Controlled Trial
- Plain-language title
- Bone marrow concentrate during hip surgery for labral tears and hip impingementGenerated from the registry record. The registry title is the official one.
- AI summary
- From the trial's eligibility criteria. Read by machine on 14 November 2026.
- Record updated
- 20 November 2024